FDAnews Drug Daily Bulletin

MOVIPREP FDA ACTION DATE ESTABLISHED

June 22, 2006
A A

Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) goal date of August 2, 2006 for MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution). Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=2762054)